ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
15 announcements with these filters
Manipal Health Enterprises disclosed a Reg 31(1) encumbrance over 17.43% of promoter shares. The pledge secures up to Rs 500 Crore of Claypond NCDs.
Manipal Health Enterprises Ltd has utilized IPO proceeds for the full redemption of its subsidiary's outstanding listed non-convertible debentures. The total nominal value redeemed is Rs. 5,310 Crore.
Manipal Health Enterprises issued a notice for its 16th Annual General Meeting scheduled for September 29, 2026, to transact ordinary and special business.
Promoters of Manipal Health Enterprises Limited created an encumbrance on 23,21,47,755 shares, representing 17.43% stake. This pertains to covenants under financing documents for NCDs worth Rs.500 Crore.
Manipal Health delivered robust Q1 FY27 results, with revenue growing 38% YoY to INR 3,091 Cr and EBITDA up 26% to INR 749 Cr, driven primarily by volume-led inpatient and outpatient growth.
Manipal Health Enterprises Limited announced the appointment of Price Waterhouse Chartered Accountants LLP as statutory auditor, effective September 29, 2026, following the tenure completion of BSR & Co. LLP.
Manipal Health delivered its first post-listing results for Q1 FY27, reporting 38.1% revenue growth driven by patient demand and Sahyadri Hospital integration. Strategy focuses on high-acuity specialties and network expansion.
Manipal Health Enterprises Ltd reported revenue from operations of ₹3,091 Cr (+38.1% YoY) and net profit of ₹243.4 Cr (-4.2% YoY) for Q1 FY27.
Manipal Health Enterprises will acquire the operations of Kinder Women’s Hospital and Fertility Centre in Bengaluru for ₹130 Crore via a Business Transfer Agreement.
Promoters of Manipal Health Enterprises have pledged shares and created non-disposal undertakings against a USD 600 million facility. This disclosure clarifies existing security arrangements.
Manipal Health Enterprises Ltd will hold a Board Meeting on August 20, 2026, to consider and approve its unaudited financial results for the quarter ended June 30, 2026.
Vistra ITCL (India) Limited, acting as a debenture trustee, has acquired a pledge over 28.06% of Manipal Health Enterprises Limited's equity shares to secure unlisted debentures.
Axis Trustee Services Limited, acting as onshore security agent, reported an encumbrance (non-disposal undertaking) over 11,66,33,996 shares of Manipal Health Enterprises Limited. This represents 8.75% diluted capital.
Manipal Health Enterprises Limited has appointed Mr. Sathish K R as the Company Secretary and Compliance Officer. He brings over 25 years of legal and secretarial experience.
Manipal Health Enterprises Limited has adopted a new Code of Practices and Procedures for Fair Disclosure of Unpublished Price Sensitive Information. This filing complies with SEBI PIT Regulations.